国产人人色I色婷婷综合久久中文字幕雪峰I奇米色777欧美一区二区I久热久热aV爽青青在线I国产av喷水I国产伦精品一区二区三区免.费I高潮av在线Iww欧美一级I91天天看I黄a在线91I九一无码中文字幕久久无码色…I丰满国产精品视频二区

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Center

Beijing to offer free HPV vaccines to seventh-grade girls

Xinhua | Updated: 2025-03-14 09:43
Share
Share - WeChat

BEIJING -- The Chinese capital plans to administer free human papillomavirus (HPV) vaccines to seventh-grade girls starting in September this year, joining several provincial-level regions and cities that have announced similar initiatives since 2021.

The vaccination campaign will utilize the domestically produced 2-valent vaccine with an aim to effectively reduce the risk of cervical cancer among women, according to a plan jointly released by the Beijing Center for Disease Prevention and Control and other relevant authorities, on Thursday.

By the end of March, girls currently in grade six are expected to be assessed for willingness to receive the vaccine, and by Oct 31, the first dose of the vaccine will be administered to the target group, per the plan.

The move is a response to a global strategy launched by the World Health Organization (WHO) to ensure that by 2030, 90 percent of girls are fully inoculated against HPV by the age of 15.

Cervical cancer was the fourth most common cancer among women worldwide in 2022, according to the WHO. Against this backdrop, China made free HPV vaccinations accessible to approximately 40 percent of girls aged 13 to 14 in 2024, as part of its ongoing work to tackle cervical cancer, according to the National Health Commission.

Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US